INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2020

Single oral administration of up to 500 mg NMN was safe and effectively metabolized without significant deleterious effects in healthy men.

Ten healthy men received single oral doses of 100, 250, and 500 mg nicotinamide mononucleotide (NMN), with clinical parameters and NMN metabolite pharmacokinetics monitored for 5 hours after each intervention. The single oral doses caused no significant clinical symptoms or changes in heart rate, blood pressure, oxygen saturation, body temperature, ophthalmic examination, or sleep quality. Laboratory analyses showed increases in serum bilirubin and decreases in serum creatinine, chloride, and blood glucose within normal ranges, independent of dose. Plasma concentrations of N-methyl-2-pyridone-5-carboxamide and N-methyl-4-pyridone-5-carboxamide increased significantly in a dose-dependent manner.

Study type
Single-arm non-randomized trial
Who was studied
10 healthy men
What was measured
Safety, clinical parameters, ophthalmic exam, sleep quality, and pharmacokinetics of NMN metabolites

THE PAPER

Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men.

Irie J, Inagaki E, Fujita M, Nakaya H, Mitsuishi M, Yamaguchi S, Yamashita K, Shigaki S, Ono T, Yukioka H, Okano H, Nabeshima YI, Imai SI, Yasui M, Tsubota K, Itoh H. Endocr J, 2020.

PubMed 31685720 ↗DOI 10.1507/endocrj.ej19-0313 ↗

Nutrients & adequacyHealthy aging & longevity

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.